NCT02565160

Brief Summary

Making the diagnosis underlying a painful, swollen joint currently involves aspiration followed by numerous microbiological and biochemical laboratory tests. This can be costly, time consuming and in the case of an acutely swollen joint, lead to a lengthy inpatient admission. There is an unmet need to provide a quick, easy, reliable dipstick like test to analyse joint fluid in the community, clinic, or emergency department setting. The investigators aim to use well established metabonomic techniques to:

  1. 1.Analyse fluid from patients with swollen joints
  2. 2.Identify potential biomarkers of inflammatory, infective and osteoarthritic causes of joint swelling
  3. 3.Correlate this with lubrication and wear properties of the fluid The long term goal is to develop time saving, cost effective, non-invasive diagnostic tests to improve management of a swollen joint. The biomedical research centre at Imperial provides a unique and unparalleled clinical and scientific environment to conduct this research. The Imperial College division of Computational and Systems Medicine has an international reputation in metabonomics and this, together with the high volume of patients with swollen joints treated at Imperial National Health Service Trust (c1000/yr) ensures that the study can take place in an environment conductive to success.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

August 20, 2019

Status Verified

August 1, 2019

Enrollment Period

6 years

First QC Date

May 28, 2015

Last Update Submit

August 16, 2019

Conditions

Keywords

OsteoarthritisSeptic Arthritis

Outcome Measures

Primary Outcomes (1)

  • Metabolic profiling of all three body fluids in 100 + patients

    14 months

Secondary Outcomes (1)

  • DNA Profiling of 100 Joint fluid samples for the assay of the microbiome

    14 months

Study Arms (3)

Septic Arthritis

Patients suspected of having septic arthritis

Procedure: Intra-articular aspiration of JointProcedure: Joint irrigation washoutProcedure: Revision Joint Arthroplasty

Osteoarthritis

Patients suffering with osteoarthritis undergoing an intervention

Procedure: Intra-articular aspiration of JointProcedure: Joint irrigation washoutProcedure: Total Joint ArthroplastyProcedure: Revision Joint Arthroplasty

Joint Revision

Patients who has a prosthetic joint in situ

Procedure: Intra-articular aspiration of JointProcedure: Revision Joint Arthroplasty

Interventions

Procedural sampling of the joint for diagnostic purposes

Joint RevisionOsteoarthritisSeptic Arthritis

Procedural washout for treatment purposes

OsteoarthritisSeptic Arthritis
Osteoarthritis
Joint RevisionOsteoarthritisSeptic Arthritis

Eligibility Criteria

Age16 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In summary we expect to recruit 150 subjects and sample three body fluid types. In some cases control and multiple time points will be collected.

You may qualify if:

  • The patients will be recruited in several scenarios.
  • Anyone receiving a diagnostic aspirate of joint.
  • Patients undergoing joint arthroscopy
  • Patients undergoing joint replacement
  • Patients undergoing prosthetic joint revision surgery

You may not qualify if:

  • No patient under 16 years or age or older than 80 years will be entered for the study.
  • Any female patient who is pregnant will be excluded.
  • Any patient medicated with anti-coagulants will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial College NHS Trust

London, W2 1NY, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, Urine and Joint Fluid

MeSH Terms

Conditions

OsteoarthritisArthritis, InfectiousArthritis, Rheumatoid

Interventions

ArthrocentesisArthroplasty, Replacement

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesInfectionsConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

ParacentesisSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesTherapeuticsSurgical Procedures, OperativeInvestigative TechniquesArthroplastyOrthopedic ProceduresPlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Chinmay Gupte, MBBChir

    Imperial College London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2015

First Posted

October 1, 2015

Study Start

October 1, 2015

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

August 20, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations